The CRONIC-PPF Faculty

	Katrin MILGER-KNEIDINGER Ass.-Prof. Priv.-Doz. Dr. med. univ. Progression and inflammation in hypersensitivity pneumonitis
Division of Pulmonology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz Phone: +43-316-385 72911, ✉ e-mail WWW: Forschungsportal Med Uni Graz ORCID: 0000-0003-2914-8773 PubMed: PubMed (nih.gov)
• Profile      • Curriculum vitae     • Publications

List of publications:

• For a full list of publications see → Fodok Med Uni Graz

10 most significant publications:

1. Götschke J, Walter J, Leuschner G, Gerckens M, Götschke M, Mertsch P, Mümmler C, Lenoir A, Barnikel M, Dinkel J, Behr J, Kneidinger N, Spiro JE, Milger K: Mucus Plug Score Predicts Clinical and Pulmonary Function Response to Biologic Therapy in Patients With Severe Asthma. J Allergy Clin Immunol Pract, 2025; S2213-2198(25)00053-4.
2. Biener L, Mümmler C, Hinze CA, Suhling H, Korn S, Fisser C, Biener A, Pizarro C, Lenoir A, Hackl C, Skowasch D, Milger K: Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany. J Allergy Clin Immunol Pract, 2024; 12(9):​2399–2407.e5.
3. Milger K, Suhling H, Skowasch D, Holtdirk A, Kneidinger N, Behr J, Timmermann H, Schulz C, Schmidt O, Ehmann R, Hamelmann E, Idzko M, Taube C, Lommatzsch M, Buhl R, Korn S: Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort. J Allergy Clin Immunol Pract, 2023; 11(9):​2701–2712.e2.
4. Milger K, Skowasch D, Hamelmann E, Mümmler C, Idzko M, Gappa M, Jandl M, Körner-Rettberg C, Ehmann R, Schmidt O, Taube C, Holtdirk A, Timmermann H, Buhl R, Korn S: Bronchodilator Reversibility in the GAN Severe Asthma Cohort. J Investig Allergol Clin Immunol, 2023; 33(6):​446–456.
5. Mümmler C, Suhling H, Walter J, Kneidinger N, Buhl R, Kayser MZ, Drick N, Behr J, Welte T, Korn S, Milger K: Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness. J Allergy Clin Immunol Pract, 2022; 10(12):​3174–3183.
6. Bergmann KC, Skowasch D, Timmermann H, Lindner R, Virchow JC, Schmidt O, Koschel D, Neurohr C, Heck S, Milger K: Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany. J Asthma Allergy, 2022; 15:​897–906.
7. Milger K, Korn S, Buhl R, Hamelmann E, Herth FJ, Gappa M, Drick N, Fuge J, Suhling H: Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort. Respir Med, 2020; 162:​105858.
8. Milger K, Yu Y, Brudy E, Irmler M, Skapenko A, Mayinger M, Lehmann M, Beckers J, Reichenberger F, Behr J, Eickelberg O, Königshoff M, Krauss-Etschmann S: Pulmonary CCR2⁺CD4⁺ T cells are immune regulatory and attenuate lung fibrosis development. Thorax, 2017; 72(11):​1007–1020.
9. Milger K, Götschke J, Krause L, Nathan P, Alessandrini F, Tufman A, Fischer R, Bartel S, Theis FJ, Behr J, Dehmel S, Mueller NS, Kneidinger N, Krauss-Etschmann S: Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach. Allergy, 2017; 72(12):​1962–1971.
10. Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N: Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell, 2011; 147(2):​293–305.

04.04.2026 CRONIC-PPF · Doctoral Programme “Clinical & Research Oriented Network for Innovative Classification of Progressive Pulmonary Fibrosis”